Correlation Between Ginkgo Bioworks and CalciMedica, Common

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ginkgo Bioworks and CalciMedica, Common at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ginkgo Bioworks and CalciMedica, Common into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ginkgo Bioworks Holdings and CalciMedica, Common Stock, you can compare the effects of market volatilities on Ginkgo Bioworks and CalciMedica, Common and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ginkgo Bioworks with a short position of CalciMedica, Common. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ginkgo Bioworks and CalciMedica, Common.

Diversification Opportunities for Ginkgo Bioworks and CalciMedica, Common

-0.47
  Correlation Coefficient

Very good diversification

The 3 months correlation between Ginkgo and CalciMedica, is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Ginkgo Bioworks Holdings and CalciMedica, Common Stock in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CalciMedica, Common Stock and Ginkgo Bioworks is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ginkgo Bioworks Holdings are associated (or correlated) with CalciMedica, Common. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CalciMedica, Common Stock has no effect on the direction of Ginkgo Bioworks i.e., Ginkgo Bioworks and CalciMedica, Common go up and down completely randomly.

Pair Corralation between Ginkgo Bioworks and CalciMedica, Common

Considering the 90-day investment horizon Ginkgo Bioworks Holdings is expected to under-perform the CalciMedica, Common. But the stock apears to be less risky and, when comparing its historical volatility, Ginkgo Bioworks Holdings is 1.23 times less risky than CalciMedica, Common. The stock trades about -0.04 of its potential returns per unit of risk. The CalciMedica, Common Stock is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  917.00  in CalciMedica, Common Stock on September 19, 2024 and sell it today you would lose (639.00) from holding CalciMedica, Common Stock or give up 69.68% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy99.79%
ValuesDaily Returns

Ginkgo Bioworks Holdings  vs.  CalciMedica, Common Stock

 Performance 
       Timeline  
Ginkgo Bioworks Holdings 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Ginkgo Bioworks Holdings are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Ginkgo Bioworks sustained solid returns over the last few months and may actually be approaching a breakup point.
CalciMedica, Common Stock 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CalciMedica, Common Stock has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's essential indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Ginkgo Bioworks and CalciMedica, Common Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ginkgo Bioworks and CalciMedica, Common

The main advantage of trading using opposite Ginkgo Bioworks and CalciMedica, Common positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ginkgo Bioworks position performs unexpectedly, CalciMedica, Common can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CalciMedica, Common will offset losses from the drop in CalciMedica, Common's long position.
The idea behind Ginkgo Bioworks Holdings and CalciMedica, Common Stock pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

CEOs Directory
Screen CEOs from public companies around the world
Commodity Directory
Find actively traded commodities issued by global exchanges
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities